Researchers test skin cancer drug for Alzheimer's treatment

09/12/2013 | KSNV-TV (Las Vegas)

A landmark study is being conducted in Las Vegas to determine the effect of bexarotene, an established skin cancer drug, on patients with Alzheimer's disease. The trial was initiated after the drug was linked to cognitive improvements in mice. Patients will undergo brain imaging to assess changes in their neurological condition.

View Full Article in:

KSNV-TV (Las Vegas)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ